A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris

Exclusion Criteria

• •1. Use of an investigational drug or device within 30 days of enrollment or participation in a research study concurrent with this study.
• •2. Any dermatological conditions on the face that could interfere with clinical evaluations such as acne conglobata, acne fulminans, secondary acne, perioral dermatitis, clinically significant rosacea, gram negative folliculitis, dermatitis, eczema.
• •3. Any underlying disease(s) or some other dermatological condition of the face that requires the use of interfering topical or systemic therapy or makes evaluations and lesion count inconclusive.
• •4. Subjects with a facial beard or mustache that could interfere with the study assessments.
• •5. Subjects with more than 2 facial nodules.
• •6. Evidence or history of cosmetic-related acne.